Isolation by Distance Between Spouses and its Effect on Boys’ Maturational Timing

Heterosis is thought to be an important contributor to human growth and development. Marital distance (distance between parental birthplaces) is commonly considered as a factor favoring the occurrence of heterosis and can be used as a proximate measure of its level. It has already been shown that marital distance appears to be an independent and important factor influencing the height of offspring. However, there is no study showing this effect on maturational timing in boys. The aim of the study was to assess the effect of marital radius on age at peak height velocity in boys, controlling for midparental height and the socioeconomic status of family. Longitudinal, annual height measurements on 740 boys from 11 to 15 years of age from Ostrowiec Świętokrzyski, Poland, were analyzed along with sociodemographic data from their parents. Midparental height was calculated as the average of the reported heights of the parents. The SITAR model was applied to the longitudinal data of height in order to assess the age at peak height velocity (APHV). As the measurements were incomplete, the APHV was successfully estimated in only 298 boys. Multiple Linear regression showed the small, but significant effect of Marital distance on the maturation rate of boys (standardized beta=-0.14; p<0.05). According to the ‘‘isolation by distance’’ hypothesis, a greater distance between parental birthplaces may increase heterozygosity, potentially promoting heterosis. We propose that these conditions may result in reduced metabolic costs of growth among heterozygous individuals, and hence a lowered velocity of growth

Waste to Carbon: Influence of Structural Modification on VOC Emission Kinetics from Stored Carbonized Refuse-Derived Fuel

The torrefaction of municipal solid waste is one of the solutions related to the Waste to Carbon concept, where high-quality fuel—carbonized refuse-derived fuel (CRDF)—is produced. An identified potential problem is the emission of volatile organic compounds (VOCs) during CRDF storage. Kinetic emission parameters have not yet been determined. It was also shown that CRDF can be pelletized for energy densification and reduced volume during storage and transportation. Thus, our working hypothesis was that structural modification (via pelletization) might mitigate VOC emissions and influence emission kinetics during CRDF storage. Two scenarios of CRDF structural modification on VOC emission kinetics were tested, (i) pelletization and (ii) pelletization with 10% binder addition and compared to ground (loose) CRDF (control). VOC emissions from simulated sealed CRDF storage were measured with headspace solid-phase microextraction and gas chromatography–mass spectrometry. It was found that total VOC emissions from stored CRDF follow the first-order kinetic model for both ground and pelletized material, while individual VOC emissions may deviate from this model. Pelletization significantly decreased (63%~86%) the maximum total VOC emission potential from stored CDRF. Research on improved sustainable CRDF storage is warranted. This could involve VOC emission mechanisms and environmental-risk management

The Influence Of Urbanization Level Of Residence On The Health-Related Fitness Of University Students

The aim of the study was to assess the influence of place of residence on the health-related fitness (H-RF) of university students from Kielce, Poland. The research included 632 first-year students from the Jan Kochanowski University in Kielce between 2015-2017. The research analyzed two basic components of H-RF─ morphological and circulatory-respiratory. In terms of the morphological component, body height and weight, as well as BMI were measured. In terms of the circulatory-respiratory component, the V̇O2max was calculated utilizing the Astrand test, that allows the assessment of V̇O2max in l / min and V̇O2max in ml / kg / min and PWC170. Data regarding place of permanent residence of the students and physical activity in their free time were collected using a questionnaire. In this respect, the urban and rural environment were distinguished. Using the Vigorous Physical Activity index, two categories of physical activity in free time were distinguished, i.e. moderate and low. The obtained results indicate a differentiation of H-RF of the student, both in relation to the place of permanent residence and physical activity in their free time, that was slightly more pronounced in men than in women. This may denote that men are more eco-sensitive, meaning that they might be more susceptible to the influence of environmental factors

Anticoagulation versus placebo for heart failure in sinus rhythm

BACKGROUND: People with chronic heart failure (HF) are at risk of thromboembolic events, including stroke, pulmonary embolism, and peripheral arterial embolism; coronary ischaemic events also contribute to the progression of HF. The use of long‐term oral anticoagulation is established in certain populations, including people with HF and atrial fibrillation (AF), but there is wide variation in the indications and use of oral anticoagulation in the broader HF population. OBJECTIVES: To determine whether long‐term oral anticoagulation reduces total deaths and stroke in people with heart failure in sinus rhythm. SEARCH METHODS: We updated the searches in CENTRAL, MEDLINE, and Embase in March 2020. We screened reference lists of papers and abstracts from national and international cardiovascular meetings to identify unpublished studies. We contacted relevant authors to obtain further data. We did not apply any language restrictions. SELECTION CRITERIA: Randomised controlled trials (RCT) comparing oral anticoagulants with placebo or no treatment in adults with HF, with treatment duration of at least one month. We made inclusion decisions in duplicate, and resolved any disagreements between review authors by discussion, or a third party. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, and assessed the risks and benefits of antithrombotic therapy by calculating odds ratio (OR), accompanied by the 95% confidence intervals (CI). MAIN RESULTS: We identified three RCTs (5498 participants). One RCT compared warfarin, aspirin, and no antithrombotic therapy, the second compared warfarin with placebo in participants with idiopathic dilated cardiomyopathy, and the third compared rivaroxaban with placebo in participants with HF and coronary artery disease. We pooled data from the studies that compared warfarin with a placebo or no treatment. We are uncertain if there is an effect on all‐cause death (OR 0.66, 95% CI 0.36 to 1.18; 2 studies, 324 participants; low‐certainty evidence); warfarin may increase the risk of major bleeding events (OR 5.98, 95% CI 1.71 to 20.93; number needed to treat for an additional harmful outcome (NNTH) 17; 2 studies, 324 participants; low‐certainty evidence). None of the studies reported stroke as an individual outcome. Rivaroxaban makes little to no difference to all‐cause death compared with placebo (OR 0.99, 95% CI 0.87 to 1.13; 1 study, 5022 participants; high‐certainty evidence). Rivaroxaban probably reduces the risk of stroke compared to placebo (OR 0.67, 95% CI 0.47 to 0.95; number needed to treat for an additional beneficial outcome (NNTB) 101; 1 study, 5022 participants; moderate‐certainty evidence), and probably increases the risk of major bleeding events (OR 1.65, 95% CI 1.17 to 2.33; NNTH 79; 1 study, 5008 participants; moderate‐certainty evidence). AUTHORS' CONCLUSIONS: Based on the three RCTs, there is no evidence that oral anticoagulant therapy modifies mortality in people with HF in sinus rhythm. The evidence is uncertain if warfarin has any effect on all‐cause death compared to placebo or no treatment, but it may increase the risk of major bleeding events. There is no evidence of a difference in the effect of rivaroxaban on all‐cause death compared to placebo. It probably reduces the risk of stroke, but probably increases the risk of major bleedings. The available evidence does not support the routine use of anticoagulation in people with HF who remain in sinus rhythm

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

Summary Background Comparable global data on health and nutrition of school-aged children and adolescents are scarce. We aimed to estimate age trajectories and time trends in mean height and mean body-mass index (BMI), which measures weight gain beyond what is expected from height gain, for school-aged children and adolescents. Methods For this pooled analysis, we used a database of cardiometabolic risk factors collated by the Non-Communicable Disease Risk Factor Collaboration. We applied a Bayesian hierarchical model to estimate trends from 1985 to 2019 in mean height and mean BMI in 1-year age groups for ages 5–19 years. The model allowed for non-linear changes over time in mean height and mean BMI and for non-linear changes with age of children and adolescents, including periods of rapid growth during adolescence. Findings We pooled data from 2181 population-based studies, with measurements of height and weight in 65 million participants in 200 countries and territories. In 2019, we estimated a difference of 20 cm or higher in mean height of 19-year-old adolescents between countries with the tallest populations (the Netherlands, Montenegro, Estonia, and Bosnia and Herzegovina for boys; and the Netherlands, Montenegro, Denmark, and Iceland for girls) and those with the shortest populations (Timor-Leste, Laos, Solomon Islands, and Papua New Guinea for boys; and Guatemala, Bangladesh, Nepal, and Timor-Leste for girls). In the same year, the difference between the highest mean BMI (in Pacific island countries, Kuwait, Bahrain, The Bahamas, Chile, the USA, and New Zealand for both boys and girls and in South Africa for girls) and lowest mean BMI (in India, Bangladesh, Timor-Leste, Ethiopia, and Chad for boys and girls; and in Japan and Romania for girls) was approximately 9–10 kg/m2. In some countries, children aged 5 years started with healthier height or BMI than the global median and, in some cases, as healthy as the best performing countries, but they became progressively less healthy compared with their comparators as they grew older by not growing as tall (eg, boys in Austria and Barbados, and girls in Belgium and Puerto Rico) or gaining too much weight for their height (eg, girls and boys in Kuwait, Bahrain, Fiji, Jamaica, and Mexico; and girls in South Africa and New Zealand). In other countries, growing children overtook the height of their comparators (eg, Latvia, Czech Republic, Morocco, and Iran) or curbed their weight gain (eg, Italy, France, and Croatia) in late childhood and adolescence. When changes in both height and BMI were considered, girls in South Korea, Vietnam, Saudi Arabia, Turkey, and some central Asian countries (eg, Armenia and Azerbaijan), and boys in central and western Europe (eg, Portugal, Denmark, Poland, and Montenegro) had the healthiest changes in anthropometric status over the past 3·5 decades because, compared with children and adolescents in other countries, they had a much larger gain in height than they did in BMI. The unhealthiest changes—gaining too little height, too much weight for their height compared with children in other countries, or both—occurred in many countries in sub-Saharan Africa, New Zealand, and the USA for boys and girls; in Malaysia and some Pacific island nations for boys; and in Mexico for girls. Interpretation The height and BMI trajectories over age and time of school-aged children and adolescents are highly variable across countries, which indicates heterogeneous nutritional quality and lifelong health advantages and risks

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight NCD Risk Factor Collaboration (NCD-RisC)

From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions, with significant variation in the magnitude of these changes across regions. We investigated how much change in mean body mass index (BMI) explains changes in the prevalence of underweight, obesity, and severe obesity in different regions using data from 2896 population-based studies with 187 million participants. Changes in the prevalence of underweight and total obesity, and to a lesser extent severe obesity, are largely driven by shifts in the distribution of BMI, with smaller contributions from changes in the shape of the distribution. In East and Southeast Asia and sub-Saharan Africa, the underweight tail of the BMI distribution was left behind as the distribution shifted. There is a need for policies that address all forms of malnutrition by making healthy foods accessible and affordable, while restricting unhealthy foods through fiscal and regulatory restrictions